| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |